Navigation Links
Statement By Dinesh Thakur Regarding US Government's Case Against Ranbaxy
Date:5/13/2013

WASHINGTON, May 13, 2013 /PRNewswire-USNewswire/ -- Today, the United States government brought to a conclusion an eight-year criminal and civil investigation of Ranbaxy Laboratories Limited, India's largest generic drug company, and Ranbaxy, Inc., Ranbaxy Pharmaceuticals, Inc., Ranbaxy Laboratories, Inc., Ranbaxy USA, Inc., and Ohm Laboratories, Inc. ("Ranbaxy"). Ranbaxy has agreed to pay $500 million to resolve allegations of falsifying drug data and systemic manufacturing violations. Ranbaxy USA Inc. has pleaded guilty to multiple criminal violations. Dinesh Thakur served as the whistleblower in this case and is the former Ranbaxy Director and Global Head, Research Information & Portfolio Management.

Statement by Dinesh Thakur :

"I am relieved that the government's investigation has concluded. I am thankful for the remarkable effort of United States Food and Drug Administration, Department of Justice, United States Attorney's Office for the District of Maryland, USAID, and State Medicaid Fraud Control Units. Their work has been tireless and dedicated.

"Eight years ago, as the Director of Project & Information Management at Ranbaxy, I discovered that the company falsified drug data and systemically violated current good manufacturing practices and good laboratory practices. Ranbaxy's management was notified of these widespread problems. When they failed to correct the problems, it left me with no choice but to alert healthcare authorities.

"I worked with U.S. regulatory authorities for two years to expose the fraud. In furtherance of this effort, I filed a lawsuit to hold Ranbaxy accountable. It took us eight years to help government authorities unravel a complicated trail of
'/>"/>

SOURCE Dinesh Thakur
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Icahn Issues Statement Regarding Amylin Pharmaceuticals
2. American Society of Hematology Statement on Senate Passage of Prescription Drug User Fee Act (PDUFA)
3. American Society of Hematology Statement on House Passage of Prescription Drug User Fee Act (PDUFA)
4. Millennium Laboratories Wins Lawsuit: Ameritox Advertisements Regarding Rx Guardian and Rx Guardian CD Contain Literally False Statements
5. Statement from the Cystic Fibrosis Foundation on Passage of the EXPERRT Act in House of Representatives
6. Lilly Statement on PDUFA Vote by Senate
7. Statement from the Cystic Fibrosis Foundation on Passage of the EXPERRT Act in the U.S. Senate
8. Lilly Statement on Affordable Care Act Ruling by Supreme Court
9. Statement from Mary Vogt, President of Home Access Health Corporation, manufacturer of the Home Access HIV-1 test system, the only over-the-counter HIV test previously approved by the FDA for at-home use.
10. CRE Statement on "Inherent Reasonableness" for Retail Pharmacy Diabetic Supplies
11. Johnson Health Tech Statement on Lance Armstrong
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... and HERZLIYA PITUACH, Israel, Nov. 25, 2014 ... or "the Company"), a clinical stage biopharmaceutical company ... targeted therapeutics for the treatment of inflammatory diseases ... previously announced underwritten public offering of 3,450,000 units, ... the Company,s common stock, par value $0.0001 per ...
(Date:11/24/2014)... -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ) announced today that ... update at the Piper Jaffray 26 th Annual Healthcare ... Time (5:30 a.m. Pacific Time), at The New York Palace ... A live audio webcast of the presentation will be available ... www.arenapharm.com . A replay of the presentation will be available ...
(Date:11/24/2014)... -- Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage company developing ... today that Sergio Traversa , chief executive officer, ... Event" Micro-Cap Growth Conference on Wednesday, December 3, 2014.  ... Bel Air Hotel, which is located at 11461 Sunset ... The presentation is scheduled for 8:30 a.m. ...
Breaking Medicine Technology:Immune Pharmaceuticals Inc. Announces Closing Of Public Offering Of Common Stock And Warrants 2Immune Pharmaceuticals Inc. Announces Closing Of Public Offering Of Common Stock And Warrants 3Immune Pharmaceuticals Inc. Announces Closing Of Public Offering Of Common Stock And Warrants 4Immune Pharmaceuticals Inc. Announces Closing Of Public Offering Of Common Stock And Warrants 5Arena Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference 2Arena Pharmaceuticals to Present at Piper Jaffray 26th Annual Healthcare Conference 3Relmada Therapeutics To Present At LD MICRO Conference 2
... , MISSISSAUGA, Ontario, Dec. 30 ... Holdings Inc. (OTC Bulletin Board: CGNH), a developer of ... IVD testing market, was interviewed in MedTech Executive. ... for developing its QL Care Analyzer device, the FDA ...
... , BOSTON, Dec. 30 Solos Endoscopy, ... looks forward to a prosperous 2010, following a solid year in ... , In the closing months of 2009, Solos Endoscopy, Inc. has ... MammoView(TM) line of surgical endoscopy instruments. This will allow the MammoView(TM) ...
Cached Medicine Technology:Dr. Yahia Gawad, CEO of CardioGenics Holdings, Inc., Interviewed in MedTech Executive 2Dr. Yahia Gawad, CEO of CardioGenics Holdings, Inc., Interviewed in MedTech Executive 3Dr. Yahia Gawad, CEO of CardioGenics Holdings, Inc., Interviewed in MedTech Executive 4Solos Endoscopy, Inc. Set to Increase Business Through Sales and Product Development in 2010 2
(Date:11/26/2014)... the video interviewing specialist, has today announced the appointment ... Officer, in addition to the formal opening of it’s ... appointed as Chief Operating Officer. He is joined by ... Officer. , Mr Jones is a seasoned tech, media ... with The Walt Disney Company and Adventis where he ...
(Date:11/26/2014)... (PRWEB) November 26, 2014 Anthropologists ... effectiveness in containing and stopping Ebola, improve international ... in healthcare systems in West Africa. , ... to Stop Ebola: Anthropologists Offer Insights,” will be ... the American Anthropological Association (AAA), Fri., Dec. 5, ...
(Date:11/26/2014)... Medical suction and vacuum products have a ... score represents steady growth in the price of medical ... a result of swelling demand for healthcare services and ... considered nondiscretionary. IBISWorld market research analyst, Anna Son, says, ... of flexibility, given the low level of price volatility ...
(Date:11/26/2014)... For those with a New Year’s resolution to ... classes at the University of Colorado Anschutz Health and ... for. The 45- 60 minute classes have just started and ... fitness club memberships. , LES MILLS BODYPUMP™ exercise classes strengthen, ... aimed at fast results , By focusing on low ...
(Date:11/26/2014)... November 26, 2014 News Facts ... expanded capabilities at RSNA 2014 in Chicago. The ... and share diagnostic images, photos, videos and documents ... booth #8107 will learn more about these innovative ... technologies and partner initiatives – that enable more ...
Breaking Medicine News(10 mins):Health News:Sonru Expansion continues with appointment of new executive team and opening of new London base 2Health News:Anthropologists Release Recommendations, Better Practices to Contain Ebola 2Health News:Anthropologists Release Recommendations, Better Practices to Contain Ebola 3Health News:Medical Suction & Vacuum Products Procurement Category Market Research Report from IBISWorld has Been Updated 2Health News:Medical Suction & Vacuum Products Procurement Category Market Research Report from IBISWorld has Been Updated 3Health News:Medical Suction & Vacuum Products Procurement Category Market Research Report from IBISWorld has Been Updated 4Health News:LES MILLS BODYPUMP™ classes come to the University of Colorado Anschutz Health and Wellness Center 2Health News:Perceptive Software to Demonstrate New Medical Content Management Features and Capabilities at RSNA 2014 2Health News:Perceptive Software to Demonstrate New Medical Content Management Features and Capabilities at RSNA 2014 3
... be genetic, researchers say , , MONDAY, Feb. 16 (HealthDay News) ... as likely to develop Parkinson,s disease, a new study finds. ... other studies have shown that people with Parkinson,s diseases are ... a family member with melanoma, they may be at risk ...
... who undergo surgery at teaching-intensive hospitals have better ... better survival rates apparently occur in white patients, ... advantage in surgical outcomes for patients in teaching-intensive ... expected from other studies," said study leader Jeffrey ...
... increase security inside and out, including children,s playgroundBROOKFIELD, ... provider of radio frequency identification monitoring systems and ... St. John,s Children,s Hospital of Springfield, Ill., to ... abduction. The recent installation of Safe Place(R) Infant/Child ...
... for nonsmokers, study finds , , MONDAY, Feb. 16 (HealthDay ... for stroke among women, with more consumption translating into ... finding stems from the tracking of both coffee habits ... women across nearly a quarter century. And it adds ...
... innovators recognized for technological breakthroughsCLEVELAND, Feb. 16 ... , is pleased to announce the winners of ... technological achievements of Northeast Ohio innovators who are ... and around the world. This year, a distinguished ...
... my 1HIE, LLC (My One ... e-Prescriptions have been sent from over 700 affiliated healthcare ... physicians to help them actively adopt the usage of ... Working with its member physicians organizations, my 1HIE ...
Cached Medicine News:Health News:Family History of Melanoma Doubles Parkinson's Risk 2Health News:White patients benefit more than blacks in surviving surgical complications at teaching hospitals 2Health News:White patients benefit more than blacks in surviving surgical complications at teaching hospitals 3Health News:RF Technologies(R) Installs Safe Place(R) Solution for Pediatric and Infant Security at St. John's Children's Hospital 2Health News:RF Technologies(R) Installs Safe Place(R) Solution for Pediatric and Infant Security at St. John's Children's Hospital 3Health News:Coffee Drinking Lowers Women's Stroke Risk 2Health News:Coffee Drinking Lowers Women's Stroke Risk 3Health News:Coffee Drinking Lowers Women's Stroke Risk 4Health News:NorTech, Crain's Cleveland Business Honor 2009 Innovation Award Winners 2Health News:NorTech, Crain's Cleveland Business Honor 2009 Innovation Award Winners 3Health News:NorTech, Crain's Cleveland Business Honor 2009 Innovation Award Winners 4Health News:NorTech, Crain's Cleveland Business Honor 2009 Innovation Award Winners 5Health News:my1HIE Reaches 1 Million e-Prescriptions 2
Micro-Kerrison Laminectomie Rongeur and Stella Punch, golden springs, with ejector. 18 cm - 7 1/8, very delicate, narrow footplate, small handle, 40 up-cutting, jaws 2 mm wide....
Kerrison (Micro) Laminectomy rongeur with ejector. 18 cm - 7 1/8, thick footplate, small handle, very delicate, 40 up-cutting, jaws 2 mm wide....
... The Tangent Posterior Impacted Instrument Set offers ... of the advantages offered by the Tangent ... preparation and the ability to reproduce the ... to ensure proper vertebral body distraction. A ...
... ValveTM, Hakim, H-V Lumbar Valve ... for meeting the complex demands ... response causes the valve to ... present, eliminating the need for ...
Medicine Products: